{
    "clinical_study": {
        "@rank": "144534", 
        "arm_group": [
            {
                "arm_group_label": "Aerobic exercise", 
                "arm_group_type": "Experimental", 
                "description": "Supervised aerobic training 3 times per week for 8 weeks (30-60 minute sessions)"
            }, 
            {
                "arm_group_label": "Usual care group", 
                "arm_group_type": "Placebo Comparator", 
                "description": "These patients will continue with their normal daily activity and will not be provided with supervised aerobic exercise training during the study period."
            }
        ], 
        "brief_summary": {
            "textblock": "Cirrhosis is associated with a reduction in muscle mass and exercise capacity.  This has an\n      impact or morbidity and mortality.  Regular aerobic exercise training is a proven effective\n      therapy to improve exercise capacity in healthy and clinical populations.  the effect of\n      this training has not yet been evaluated in cirrhosis.  The safety of this intervention also\n      requires further study.  Using a randomized controlled design, the investigators aim to\n      conduct a pilot study evaluating the safety and efficacy of eight weeks of aerobic exercise\n      training on aerobic capacity."
        }, 
        "brief_title": "Effects of Aerobic Training on Exercise Capacity in Patients With Cirrhosis", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "condition": "Cirrhosis", 
        "condition_browse": {
            "mesh_term": [
                "Liver Cirrhosis", 
                "Fibrosis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age \u226518 and \u226470 years\n\n          -  Cirrhosis\n\n          -  Child Pugh class A or B\n\n          -  If required, primary or secondary variceal prophylaxis in place\n\n        Exclusion Criteria:\n\n          -  Post-liver transplantation\n\n          -  Hepatocellular carcinoma\n\n          -  Active non-Hepatocellular carcinoma malignancy\n\n          -  Significant cardiac disease - ejection fraction <60% or known coronary artery disease\n\n          -  Oxygen saturation at rest <95%\n\n          -  Known myopathy\n\n          -  Hemoglobin (<100 g/L)\n\n          -  Chronic renal failure on dialysis\n\n          -  Physical impairment making it impossible to ride an exercise bike or treadmill\n\n          -  Orthopedic abnormality preventing exercise training\n\n          -  HIV infection\n\n          -  Patient unwilling to consent to study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01799785", 
            "org_study_id": "LZPTMH1"
        }, 
        "intervention": [
            {
                "arm_group_label": "Aerobic exercise", 
                "description": "Aerobic exercise for 8 weeks (3 times per week, 30-60 minutes each session)", 
                "intervention_name": "Aerobic exercise", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Usual care group", 
                "intervention_name": "Usual Care", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 8, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Edmonton", 
                    "country": "Canada", 
                    "state": "Alberta", 
                    "zip": "T6G2B1"
                }, 
                "name": "University of Alberta, Mazankowski Heart Institute"
            }
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "2", 
        "official_title": "Aerobic Training in Patients With Cirrhosis", 
        "overall_official": {
            "affiliation": "University of Alberta", 
            "last_name": "Mark Haykowsky", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Canada: Ethics Review Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Change in peak exercise pulmonary oxygen uptake (peak VO2)", 
            "safety_issue": "No", 
            "time_frame": "Baseline (day 1) and Study End (8 weeks)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01799785"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Alberta", 
            "investigator_full_name": "Puneeta Tandon", 
            "investigator_title": "Associate Professor Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change in muscle mass as measured by thigh ultrasound", 
                "safety_issue": "No", 
                "time_frame": "Baseline (day 1) and study end (8 weeks)"
            }, 
            {
                "measure": "Change in Quality of Life - Chronic Liver Disease Questionnaire", 
                "safety_issue": "No", 
                "time_frame": "Baseline (day 1) and Study End (8 weeks)"
            }
        ], 
        "source": "University of Alberta", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Alberta", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}